Wave Life Sciences (WVE) Accumulated Expenses (2014 - 2026)

Wave Life Sciences' Accumulated Expenses history runs 13 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• Quarterly Accumulated Expenses rose 196.7% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (up 196.7% YoY) and the FY2025 annual result came in at $26.6 million, up 2166.55% from the prior year.
• Accumulated Expenses was $4.9 million for Q1 2026 at Wave Life Sciences, down from $26.6 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $26.6 million in Q4 2025 and bottomed at $476000.0 in Q1 2022.
• A 5-year average of $5.5 million and a median of $1.8 million in 2023 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2022 — Accumulated Expenses plunged 92.85% — and 2025, when it surged 2166.55%.
• Wave Life Sciences' Accumulated Expenses stood at $12.3 million in 2022, then tumbled by 85.61% to $1.8 million in 2023, then tumbled by 33.71% to $1.2 million in 2024, then jumped by 2166.55% to $26.6 million in 2025, then slumped by 81.73% to $4.9 million in 2026.
• Business Quant data shows WVE's Accumulated Expenses at $4.9 million in Q1 2026, $26.6 million in Q4 2025, and $757000.0 in Q3 2025.